The Union Minister of State for Health and Family Welfare Dr Bharati Pravin Pawar highlighted the mutual solidarity and relentless support between India and the US during the Covid-19 pandemic. She said at the inaugural session of the 4th Indo-US Health Dialogue today.
Hosted by India, the two-day Dialogue is a platform to deliberate upon multiple ongoing collaborations in the health sector between the two countries. The issues planned for deliberations in this round also encompass areas of concern pertaining to strengthening of epidemiological research and surveillance, vaccine development, One Health, zoonotic and vector-borne diseases, health systems and health policies, among others.
The union minister commended the way in which India and the US have enhanced collaboration in research and development, especially with respect to pharmaceuticals, therapeutics, and vaccine development, which could be seen in Indian vaccine companies collaborating with US-based agencies to develop the Covid-19 vaccine.
Recognising the MoU signed in 2020 on mental health, Dr Pawar acknowledged enhanced cooperation and strengthen bilateral ties in the health sector between both countries. Another MoU between the Union Ministry of Health and Family Welfare and the Department of Health and Human Services of the US, in the health sector, has been finalised, with major areas of cooperation covering issues like Health Safety and Security; Communicable Diseases & Non-Communicable Diseases; Health Systems; and Health Policy.
She recapitulated the need to focus on these emerging areas to prevent and control infectious diseases relying on well-designed and validated scientific approaches and collaboration between countries to aid in advance scientific discovery and management of global health threats. She also recognized that the public and private sectors should work together and combine their strengths in fighting the inequities of the health systems through innovations.
Marking the beginning of the two-day dialogue, she recognised that the platform will provide an opportunity to all the participants for detailed deliberations which may be used to broaden the scope of partnership on the health agenda with multiple agencies both in India and the US.